Literature DB >> 16127201

Myocardial infarction in a 17-year-old body builder using clenbuterol.

Beata Kierzkowska1, Jerzy Stańczyk, Jarosław D Kasprzak.   

Abstract

A case of non-Q myocardial infarction in a previously healthy 17-year-old body builder, who used clenbuterol, a long-acting beta(2) adrenergic agonist with anabolic and lipolytic effects, is reported. Only 1 case report of myocardial infarction associated with the use of clenbuterol was found in a literature review and that case was, however, associated with anabolic steroid use. This is the first case report to describe myocardial infarction in a young male body builder only taking clenbuterol.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16127201     DOI: 10.1253/circj.69.1144

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  8 in total

Review 1.  Comprehensive review of cardiovascular toxicity of drugs and related agents.

Authors:  Přemysl Mladěnka; Lenka Applová; Jiří Patočka; Vera Marisa Costa; Fernando Remiao; Jana Pourová; Aleš Mladěnka; Jana Karlíčková; Luděk Jahodář; Marie Vopršalová; Kurt J Varner; Martin Štěrba
Journal:  Med Res Rev       Date:  2018-01-05       Impact factor: 12.944

Review 2.  Alternative drugs of abuse.

Authors:  M E Sutter; J Chenoweth; T E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

3.  Clenbuterol-Induced Myocarditis: A Case Report.

Authors:  Natassja Moriarty; Nadeem Attar
Journal:  Eur J Case Rep Intern Med       Date:  2020-06-24

4.  Beta2 adrenergic agonist, clenbuterol, enhances working memory performance in aging animals.

Authors:  Brian P Ramos; Leslie A Colgan; Eric Nou; Amy F T Arnsten
Journal:  Neurobiol Aging       Date:  2007-03-23       Impact factor: 4.673

5.  Clenbuterol: a new toxic substance in paediatrics.

Authors:  Andrew A Tester; Sheena Logan; Louisa Pollock; Allison McKie
Journal:  BMJ Case Rep       Date:  2020-03-12

6.  Relative myotoxic and haemodynamic effects of the beta-agonists fenoterol and clenbuterol measured in conscious unrestrained rats.

Authors:  Jatin G Burniston; Lip-Bun Tan; David F Goldspink
Journal:  Exp Physiol       Date:  2006-09-14       Impact factor: 2.969

7.  Anabolic drugs and myocardial infarction - a clinical case report.

Authors:  Rui Pontes Santos; Adriana Pereira; Henrique Guedes; Carolina Lourenço; João Azevedo; Paula Pinto
Journal:  Arq Bras Cardiol       Date:  2015-09       Impact factor: 2.000

8.  Recruitment to doping and help-seeking behavior of eight female AAS users.

Authors:  Annica Börjesson; Nina Gårevik; Marja-Liisa Dahl; Anders Rane; Lena Ekström
Journal:  Subst Abuse Treat Prev Policy       Date:  2016-03-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.